dyslipidemia therapy (Bayer)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedyslipidemia therapy (Bayer)
Drug Alias Namethyromimetic (Bayer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor agonists
TargetsThyroid hormone receptor
Therapy Area/IndicationsLipid Metabolism DisordersArteriosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersArteriosclerosis

Other Information

ATC CodeN/A
Related LinksN/A